Literature DB >> 23237753

Relationship between the timing of cataract surgery and development of nystagmus in patients with bilateral infantile cataracts.

Marielle P Young1, Gena Heidary, Deborah K VanderVeen.   

Abstract

PURPOSE: To study the relationship between timing of surgery as a risk factor for the development of manifest nystagmus in patients with bilateral infantile cataracts and to determine the effect of nystagmus on visual outcomes.
METHODS: The medical records of patients with bilateral infantile cataracts operated on before 12 months of age between January 1991 and December 2009 were retrospectively reviewed. Patients were stratified into two groups: early (age <8 weeks) or late (age >8 weeks) surgery.
RESULTS: A total of 56 patients (29 males) were studied. Early surgery was performed in 26 patients. Of these, 10 (38%) had manifest nystagmus at the most recent follow-up. Of 30 patients who underwent late surgery, 15 (50%) had manifest nystagmus at the most recent follow-up. There was not a statistically significant impact on the timing of cataract surgery and the development of postoperative nystagmus (P = 0.43). In total, 25 of 56 (45%) patients had postoperative manifest nystagmus; in these patients, there was a statistically significant decrement in final logMAR visual outcomes compared with those patients without postoperative nystagmus (0.26 vs 0.16; P = 0.04); however, preoperative nystagmus did not appear to be a risk factor for a worse visual outcome.
CONCLUSIONS: Manifest nystagmus is a common feature in children with bilateral infantile cataracts, regardless of the timing of surgery. Early surgery as defined in this study does not necessarily prevent its development. Postoperative nystagmus is more common when surgery is performed later but can improve as the child matures.
Copyright © 2012 American Association for Pediatric Ophthalmology and Strabismus. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23237753     DOI: 10.1016/j.jaapos.2012.08.008

Source DB:  PubMed          Journal:  J AAPOS        ISSN: 1091-8531            Impact factor:   1.220


  6 in total

Review 1.  Molecular Genetics of Cataract.

Authors:  Alan Shiels; J Fielding Hejtmancik
Journal:  Prog Mol Biol Transl Sci       Date:  2015-06-12       Impact factor: 3.622

2.  Lens regeneration in children.

Authors:  Demetrios G Vavvas; Thaddeus P Dryja; M Edward Wilson; Timothy W Olsen; Ankoor Shah; Ula Jurkunas; Roberto Pineda; Vasiliki Poulaki; Sotiria Palioura; Peter Veldman; Javier Moreno-Montañés; Maria D Pinazo-Duran; José Carlos Pastor; Miltiadis Tsilimbaris; Douglas Rhee; Kathryn Colby; David G Hunter; Solon Thanos; Taiji Sakamoto; Louis R Pasquale; Joan W Miller; Deborah VanderVeen; Scott R Lambert
Journal:  Nature       Date:  2018-04-04       Impact factor: 49.962

3.  Liu et al. reply.

Authors:  Yizhi Liu; David Granet; Haotian Lin; Sally Baxter; Hong Ouyang; Jie Zhu; Shan Huang; Zhenzhen Liu; Xiaokang Wu; Fangbing Yan; Xialin Liu; Lixia Luo; Christopher Heichel; Meixia Zhang; Wenjia Cai; Richard L Maas; Kang Zhang
Journal:  Nature       Date:  2018-04-04       Impact factor: 49.962

4.  Timing and approaches in congenital cataract surgery: a four-year, two-layer randomized controlled trial.

Authors:  Hao-Tian Lin; Er-Ping Long; Jing-Jing Chen; Zhen-Zhen Liu; Zhuo-Ling Lin; Qian-Zhong Cao; Xia-Yin Zhang; Xiao-Hang Wu; Qi-Wei Wang; Duo-Ru Lin; Xiao-Yan Li; Jin-Chao Liu; Li-Xia Luo; Bo Qu; Wei-Rong Chen; Yi-Zhi Liu
Journal:  Int J Ophthalmol       Date:  2017-12-18       Impact factor: 1.779

5.  Exome sequencing identifies novel and recurrent mutations in GJA8 and CRYGD associated with inherited cataract.

Authors:  Donna S Mackay; Thomas M Bennett; Susan M Culican; Alan Shiels
Journal:  Hum Genomics       Date:  2014-11-18       Impact factor: 4.639

6.  Outcome of Pediatric Cataract Surgeries in a Tertiary Center in Switzerland.

Authors:  Sarah Claudia Ambroz; Marc Töteberg-Harms; James V M Hanson; Jens Funk; Daniel Barthelmes; Christina Gerth-Kahlert
Journal:  J Ophthalmol       Date:  2018-02-25       Impact factor: 1.909

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.